Brief: Immunovia To Receive About SEK 100 Mln From Rights Issue
26/09/2025 06:50
Sept 26 (Reuters) - Immunovia AB IMMNOV.ST: SAID ON THURSDAY WILL RECEIVE FROM RIGHTS ISSUE ABOUT SEK 100 MILLION BEFORE ISSUE COSTS RIGHTS ISSUE ENTAILS ISSUANCE OF UP TO 333,908,814 SHARES SUBSCRIPTION PRICE HAS BEEN SET TO SEK 0.30 PER SHARE TO USE NET PROCEEDS FROM RIGHTS ISSUE TO FINANCE COMMERCIAL LAUNCH OF PANCREASURE DURING H2 2025 AND ADDITIONAL STUDIES SUPPORTING REIMBURSEMENT IN U.S. RIGHTS ISSUE SUBJECT TO APPROVAL BY EGM ON SEPTEMBER 29 Source text for Workspace: nNDLF476N Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))